GlassScriptPhysician profile
Tracy M Fite
NPI 1578697074
$889.38
in general payments reported to CMS, 2019-2025
22 companies · $167 in 2025
The $167 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.17 · 2021: $195 · 2022: $194 · 2023: $226 · 2024: $69.90 · 2025: $167.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $463.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $124.52 | 2022-2024 | |
| Exact Sciences Corporation | $97.72 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $93.61 | 2021-2025 | Zepbound, Mounjaro, Taltz |
| Abbvie INC. | $77.61 | 2021-2023 | |
| Organon LLC | $72.62 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $70.81 | 2021-2025 | Rexulti |
| Mallinckrodt Hospital Products INC. | $39.21 | 2022 | |
| Novo Nordisk INC | $39.17 | 2021-2025 | Wegovy |
| Tactile Systems Technology INC | $33.69 | 2025 | Nimbl, Flexitouch Plus |
| Sanofi-Aventis U.S. LLC | $33.58 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $26.56 | 2022-2023 | M-M-R II, Gardasil 9, Vaxelis |
| Vanda Pharmaceuticals INC. | $20.99 | 2025 | Fanapt |
| Dexcom, INC. | $19.47 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $19.21 | 2023 | Seglentis |
| Axonics, INC. | $17.72 | 2023 | Axonics |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $17.38 | 2022 | |
| Glaxosmithkline, LLC. | $16.72 | 2022 | |
| Amgen INC. | $15.11 | 2023 | Evenity, Prolia |
| Janssen Pharmaceuticals, INC | $14.43 | 2021 | |
| Alexion Pharmaceuticals, INC. | $14.41 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $12.73 | 2020 | |
| Eisai INC. | $12.11 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Fite listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.